Monthly analysis: May 2021
Month: June 2021
Corporates journey to South Africa
Innovative region: South Africa
SoftBank meets IRL for $170m series C
The events-focused social network secured its latest funding at a $1.2bn valuation, in a round led by SoftBank Vision Fund 2.
Notes from the Bund
Comment by Nick Yusko, chief executive and chief investment officer, Morgan Creek Capital Management
RayzeBio receives $108m in series C funding
Alexandria Venture Investments returned to invest in a series C round that lifted the radiopharmaceutical developer’s overall funding to $258m.
Duda develops with $50m series D
Susquehanna Growth Equity has returned to reinvest in the web design platform operator, which has amassed $100m in funding in total.
Camp4 collects $45m capital injection
Kraft Group has once again participated in a funding round for the RNA drug developer, having backed its series A round three years ago.
Structuring a CVC: invest on market terms
Comment from Patrick Flesner, partner, LeadX Capital Partners, and Stephan Bank, partner, SMP
Life sciences sector gives hope and continues to grow
Sector report: Healthcare
BAT unveils corporate venture capital arm
BAT is vying to become a leader in the on-the-go wellbeing and stimulation space through a new corporate venturing unit that has been quietly investing in the space since last summer.
Sanity Group snatches series A funds
German Media Pool was among the participants in a $44.2m round that will fund the building of the cannabinoid product developer’s production and research facility.
Learn from the best
June 2021 issue editorial by James Mawson, editor in chief, Global Corporate Venturing
Daily Deal Round Up: June 15, 2021
Gene therapy startup VectorY has raised more than $37m in an Eli Lilly-backed seed round while AR helmet developer XYZ Reality pulled in over $28m.
Rising Stars Q&A – Ginger Rothrock, HG Ventures
Q&A with Ginger Rothrock, senior director, HG Ventures